Table 2.
Baseline demographics and risk factors between the hypothermia and normothermia groups. (* peripheral vascular disease)
| Hypothermia (Group 2, 5, 6) n=28 | Normothermia (Group 1, 3,4) n=30 | Fisher’s Exact Test p-value: | |
|---|---|---|---|
| Male gender | 56.7% | 53.8% | 0.999 |
| Race (white) | 89.3% | 80.0% | 0.707 |
| Age in years (±SD) | 68.9 (7.9) | 62.3 (14.5) | 0.109 |
| Known atrial fibrillation | 21.4% | 13.3% | 0.499 |
| Diabetes | 21.4% | 30.0% | 0.554 |
| Arterial hypertension | 71.4% | 63.3% | 0.583 |
| Hyperlipidemia | 53.7% | 50.0% | 0.793 |
| Present smoking | 10.7% | 26.7% | 0.102 |
| Congestive heart failure | 3.6% | 16.7% | 0.109 |
| PVD* | 3.6% | 6.7% | 0.411 |
| Myocardial infarction | 14.3% | 16.7% | 0.426 |
| Coronary artery disease | 39.4% | 26.7% | 0.695 |
| Prior stroke or TIA | 17.9% | 20.0% | 0.869 |
| Liver disease | 3.6% | 0 | 0.229 |
| Lung disease | 10.7% | 13.3% | 0.848 |
| Renal disease | 7.1% | 13.3% | 0.671 |
| Gastrointestinal disease | 21.4% | 33.3% | 0.298 |
| Pre-stroke Modified Rankin >1 | 14.3% | 3.3% | 0.214 |
| Pre-treatment NIHSS (±SD) | 14.3(5.0) | 13.7(5.1) | 0.651 |
Peripheral Vascular Disease